GlassScriptPhysician profile
Manisha S Parikh
NPI 1770625196
$3,490.90
in general payments reported to CMS, 2019-2025
44 companies · $848 in 2025
The $848 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $841 · 2020: $268 · 2021: $323 · 2022: $407 · 2023: $172 · 2024: $631 · 2025: $848.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,576 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,575.52 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $526.67 | 2024-2025 | Zurzuvae, Vumerity |
| Abbvie INC. | $358.75 | 2019-2025 | |
| Pfizer INC. | $303.41 | 2019-2024 | |
| Astellas Pharma US INC | $246.72 | 2019-2025 | Veozah |
| Exeltis, USA INC. | $205.08 | 2019-2025 | Slynd |
| Shield Therapeutics INC | $196.80 | 2024-2025 | |
| Organon LLC | $158.84 | 2022-2025 | Nexplanon |
| Millicent US INC | $115.34 | 2019-2025 | Femlyv, Intrarosa |
| Vertical Pharmaceuticals, LLC | $107.40 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $102.32 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $97.40 | 2025 | Myfembree, Gemtesa |
| Therapeuticsmd, INC. | $79.97 | 2019-2022 | |
| Allergan, INC. | $73.61 | 2019-2020 | |
| Avion Pharmaceuticals | $67.63 | 2019-2020 | |
| Evofem Biosciences, INC. | $64.78 | 2020-2025 | Solosec, Phexx, Phexxi |
Show all 43 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manisha Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.